Cox Jason Douglas, Oloruntoba Ayooluwatomiwa I, Booth Kate, Murphy Travis, Knott Cameron, Lee Chun Hin Angus
Bendigo Health, Monash University School of Rural Health, Bendigo, Victoria, Australia.
Alfred Health, Monash University, Melbourne, Victoria, Australia.
ANZ J Surg. 2025 Aug 22. doi: 10.1111/ans.70299.
The Australian and New Zealand Emergency Laparotomy Audit (ANZELA) was implemented as standard-of-care for Emergency Major Abdominal Surgery (EMAS) at Bendigo Health in September 2021. All EMAS patients undergo routine preoperative risk assessment (RPRA) using the 'National Emergency Laparotomy Audit (NELA) Calculator.' Patients with NELA mortality risk estimates ≥ 10% are considered 'high-risk' and routinely referred to the Intensive Care Unit (ICU) for planned postoperative admission. This study aims to identify whether RPRA and routine ICU referral for high-risk EMAS patients is a cost-effective intervention that improves postoperative outcomes in a rural health service.
This study is a retrospective audit of high-risk adult patients who underwent EMAS at Bendigo Health between September 2017 and August 2023. Postoperative outcomes and costs were compared before and after implementation of ANZELA. A cost-effectiveness analysis was subsequently conducted to estimate the additional cost required to improve postoperative outcomes and presented as incremental cost-effectiveness ratios (ICERs).
A total of 191 high-risk EMAS patients were identified. The mean postoperative cost of care was AUD$52 338.78, with no significant change post-ANZELA (p = 0.983). Post-ANZELA, there was a 15.3% reduction in the rate of planned ICU admissions (p = 0.026), a 10.9% reduction in the rate of unplanned returns to theatre (p = 0.045), and a 16.83% reduction in the rate of severe postoperative complications (p = 0.03). There was no significant change in postoperative mortality (p = 0.59).
RPRA and routine ICU referral of high-risk EMAS improve perioperative outcomes without increasing cost-of-care. This protocol may therefore be a cost-effective tool to guide the perioperative care of EMAS patients.
澳大利亚和新西兰急诊剖腹手术审计(ANZELA)于2021年9月在本迪戈健康中心作为急诊重大腹部手术(EMAS)的护理标准实施。所有EMAS患者均使用“国家急诊剖腹手术审计(NELA)计算器”进行常规术前风险评估(RPRA)。NELA死亡风险估计≥10%的患者被视为“高危”,并常规转诊至重症监护病房(ICU)进行术后计划内入院。本研究旨在确定RPRA以及对高危EMAS患者进行常规ICU转诊是否是一种具有成本效益的干预措施,可改善农村医疗服务中的术后结局。
本研究是对2017年9月至2023年8月在本迪戈健康中心接受EMAS的高危成年患者进行的回顾性审计。比较了ANZELA实施前后的术后结局和成本。随后进行了成本效益分析,以估计改善术后结局所需的额外成本,并以增量成本效益比(ICER)表示。
共确定了191例高危EMAS患者。术后护理的平均成本为52338.78澳元,ANZELA实施后无显著变化(p = 0.983)。ANZELA实施后,计划内ICU入院率降低了15.3%(p = 0.026),非计划返回手术室率降低了10.9%(p = 0.045),严重术后并发症率降低了16.83%(p = 0.03)。术后死亡率无显著变化(p = 0.59)。
高危EMAS患者的RPRA和常规ICU转诊可改善围手术期结局,而不会增加护理成本。因此,该方案可能是指导EMAS患者围手术期护理的一种具有成本效益的工具。